Hybrid quantum cycle generative adversarial network for small molecule generation

• URL: http://arxiv.org/abs/2402.00014v1
• Date: Thu, 28 Dec 2023 14:10:26 GMT
• Title: Hybrid quantum cycle generative adversarial network for small molecule generation
• Authors: Matvei Anoshin, Asel Sagingalieva, Christopher Mansell, Vishal Shete, Markus Pflitsch, and Alexey Melnikov
• Abstract summary: This work introduces several new generative adversarial network models based on engineering integration of parametrized quantum circuits into known molecular generative adversarial networks. The introduced machine learning models incorporate a new multi- parameter reward function grounded in reinforcement learning principles.
• Score: 0.0
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: The contemporary drug design process demands considerable time and resources to develop each new compound entering the market. Generating small molecules is a pivotal aspect of drug discovery, essential for developing innovative pharmaceuticals. Uniqueness, validity, diversity, druglikeliness, synthesizability, and solubility molecular pharmacokinetic properties, however, are yet to be maximized. This work introduces several new generative adversarial network models based on engineering integration of parametrized quantum circuits into known molecular generative adversarial networks. The introduced machine learning models incorporate a new multi-parameter reward function grounded in reinforcement learning principles. Through extensive experimentation on benchmark drug design datasets, QM9 and PC9, the introduced models are shown to outperform scores achieved previously. Most prominently, the new scores indicate an increase of up to 30% in the druglikeness quantitative estimation. The new hybrid quantum machine learning algorithms, as well as the achieved scores of pharmacokinetic properties, contribute to the development of fast and accurate drug discovery processes.

Related papers

• Discovering intrinsic multi-compartment pharmacometric models using Physics Informed Neural Networks [0.0]
  We introduce PKINNs, a novel purely data-driven neural network model. PKINNs efficiently discovers and models intrinsic multi-compartment-based pharmacometric structures. The resulting models are both interpretable and explainable through Symbolic Regression methods.
  arXiv  Detail & Related papers  (2024-04-30T19:31:31Z)
• Quantum Computing-Enhanced Algorithm Unveils Novel Inhibitors for KRAS [10.732020360180773]
  We introduce a quantum-classical generative model that seamlessly integrates the power of quantum algorithms trained on a 16-qubit IBM quantum computer. Our work shows for the first time the use of a quantum-generative model to yield experimentally confirmed biological hits.
  arXiv  Detail & Related papers  (2024-02-13T04:19:06Z)
• Implicit Geometry and Interaction Embeddings Improve Few-Shot Molecular Property Prediction [53.06671763877109]
  We develop molecular embeddings that encode complex molecular characteristics to improve the performance of few-shot molecular property prediction. Our approach leverages large amounts of synthetic data, namely the results of molecular docking calculations. On multiple molecular property prediction benchmarks, training from the embedding space substantially improves Multi-Task, MAML, and Prototypical Network few-shot learning performance.
  arXiv  Detail & Related papers  (2023-02-04T01:32:40Z)
• Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning [82.93806087715507]
  Drug combination therapy is a well-established strategy for disease treatment with better effectiveness and less safety degradation. Deep learning models have emerged as an efficient way to discover synergistic combinations. Our framework achieves state-of-the-art results in comparison with other deep learning-based methods.
  arXiv  Detail & Related papers  (2023-01-14T15:07:43Z)
• Exploring the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry [8.98977891798507]
  We proposed a hybrid quantum-classical generative adversarial network (GAN) for small molecule discovery. We substituted each element of GAN with a variational quantum circuit (VQC) and demonstrated the quantum advantages in the small drug discovery.
  arXiv  Detail & Related papers  (2022-10-30T11:57:56Z)
• Retrieval-based Controllable Molecule Generation [63.44583084888342]
  We propose a new retrieval-based framework for controllable molecule generation. We use a small set of molecules to steer the pre-trained generative model towards synthesizing molecules that satisfy the given design criteria. Our approach is agnostic to the choice of generative models and requires no task-specific fine-tuning.
  arXiv  Detail & Related papers  (2022-08-23T17:01:16Z)
• Exploring Chemical Space with Score-based Out-of-distribution Generation [57.15855198512551]
  We propose a score-based diffusion scheme that incorporates out-of-distribution control in the generative differential equation (SDE) Since some novel molecules may not meet the basic requirements of real-world drugs, MOOD performs conditional generation by utilizing the gradients from a property predictor. We experimentally validate that MOOD is able to explore the chemical space beyond the training distribution, generating molecules that outscore ones found with existing methods, and even the top 0.01% of the original training pool.
  arXiv  Detail & Related papers  (2022-06-06T06:17:11Z)
• Drug Discovery Approaches using Quantum Machine Learning [10.321495133438242]
  Deep generative and predictive models are widely adopted to assist in drug development. We propose a suite of quantum machine learning techniques to generate small drug molecules, classify binding pockets in proteins, and generate large drug molecules.
  arXiv  Detail & Related papers  (2021-04-01T19:53:06Z)
• MIMOSA: Multi-constraint Molecule Sampling for Molecule Optimization [51.00815310242277]
  generative models and reinforcement learning approaches made initial success, but still face difficulties in simultaneously optimizing multiple drug properties. We propose the MultI-constraint MOlecule SAmpling (MIMOSA) approach, a sampling framework to use input molecule as an initial guess and sample molecules from the target distribution.
  arXiv  Detail & Related papers  (2020-10-05T20:18:42Z)
• Generative chemistry: drug discovery with deep learning generative models [0.0]
  This paper reviews the latest advances in generative chemistry which relies on generative modeling to expedite the drug discovery process. The detailed discussions on utilizing cutting-edge generative architectures, including recurrent neural network, variational autoencoder, adversarial autoencoder, and generative adversarial network for compound generation are focused.
  arXiv  Detail & Related papers  (2020-08-20T14:38:21Z)
• Learning To Navigate The Synthetically Accessible Chemical Space Using Reinforcement Learning [75.95376096628135]
  We propose a novel forward synthesis framework powered by reinforcement learning (RL) for de novo drug design. In this setup, the agent learns to navigate through the immense synthetically accessible chemical space. We describe how the end-to-end training in this study represents an important paradigm in radically expanding the synthesizable chemical space.
  arXiv  Detail & Related papers  (2020-04-26T21:40:03Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.